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Purpose: Target-controlled infusion (TCI) of remifentanil can suppress coughing 
during emergence from general anesthesia; nevertheless, previous studies under 
different clinical conditions recommend significantly different effective effect-site 
concentrations (effective Ce) of remifentanil for 50% of patients (EC50). The dif-
ferences among these studies include type of surgery and patient sex. In recent 
years, study of sex differences in regards to anesthetic pharmacology has drawn 
greater interest. Accordingly, we attempted to determine the effective Ce of remi-
fentanil for preventing cough for each sex under the same clinical conditions. Ma-
terials and Methods: Twenty female and 25 male ASA physical status I-II grade 
patients between the ages of 20 and 46 years who were undergoing thyroidectomy 
were enrolled in this study. The effective Ce of remifentanil for preventing cough 
was determined for each sex using the isotonic regression method with a boot-
strapping approach, following Dixon’s up-and-down method. Results: Isotonic re-
gression with a bootstrapping approach revealed that the estimated EC50 of remi-
fentanil for preventing coughing during emergence was significantly lower in 
females {1.30 ng/mL [83% confidence interval (CI), 1.20-1.47 ng/mL]} than in 
males [2.57 ng/mL (83% CI, 2.45-2.70 ng/mL)]. Mean EC50 in females was also 
significantly lower than in males (1.23±0.21 ng/mL vs. 2.43±0.21 ng/mL, 
p<0.001). Mean arterial pressure, heart rate, and respiratory rate over time were 
not significantly different between the sexes. Conclusion: When using remifent-
anil TCI for cough prevention during anesthetic emergence, patient sex should be 
a considered for appropriate dosing.
Key Words:   Sex difference, effect-site concentration, general anesthesia, remifen-
tanil, target-controlled infusion, cough prevention
INTRODUCTION
 
Airway reflexes, including coughing, are commonly considered normal responses 
during emergence from general anesthesia.1-3 However, coughing during emergence 
may lead to a number of potentially dangerous side effects, including laryngospasm, 
detrimental hemodynamic changes, and increased intraocular and intracranial pres-
sure. Reportedly, post-thyroidectomy bleeding resulting in acute airway obstruction 
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ing anesthetic emergence than women. The purpose of this 
study was to determine the EC50 of remifentanil in effect-
site TCI for preventing cough in males and females under 
the same clinical conditions and evaluate whether there are 
sex differences in EC50 of remifentanil for emergence cough 
suppression.
MATERIALS AND METHODS
　　　
This study was approved by the Institutional Review Board 
of Severance Hospital, Yonsei University Health System 
(Ref: 4-2011-0356) and registered at http://ClinicalTrials.
gov (Ref: NCT01614535). Written informed consent was 
obtained from all subjects. We enrolled 30 male and 23 fe-
male patients of ages 20 to 46 years and of ASA I-II status, 
all of whom underwent general anesthesia for elective thy-
roidectomy. Exclusion criteria included patients who exhib-
ited signs of a difficult airway, upper respiratory infection 
in the previous two weeks, hypertension, or diabetes melli-
tus. Current smokers were excluded, and female patients 
who were pregnant, breast-feeding, or menopausal were 
also excluded. In addition, we withdrew patients who expe-
rienced delayed emergence and had not regained con-
sciousness by 15 min after the main anesthetic agent had 
been stopped.
The patients were not premedicated. After arrival at the 
operating room, routine monitoring, including electrocar-
diogram, peripheral oxygen saturation, non-invasive arteri-
al pressure, end-tidal carbon dioxide (EtCO2), and nasopha-
ryngeal temperature, were performed at 1-5 min intervals. 
Bispectral index (BIS) (BIS® monitor, Covidien Medical, 
Boulder, CO, USA) monitoring was also performed. Anes-
thesia was induced using propofol 1.5-2.5 mg/kg I.V. and 
remifentanil TCI. For TCI of remifentanil, a commercial 
TCI pump (Orchestra® Base Primea, Fresenius Vial, France) 
was used, and pump operation was based on the pharmaco-
kinetic model of Minto, et al.20 After non-response to verbal 
orders and loss of eyelid reflex, rocuronium 0.6 mg/kg I.V. 
was administered. Tracheal intubation was performed in all 
patients using a 6.5 mm (internal diameter) tracheal tube for 
females and a 7.5 mm tracheal tube for males. Cuff pressure 
was maintained at 20-25 cmH2O using a hand pressure 
gauge (Hi-LoTM Hand Pressure Gauge, VBM Medizintech-
nik GmbH, Germany). Anesthesia was maintained with 
sevoflurane at 1.5-2.5 vol% in an air/oxygen mixture (FIO2: 
0.5, 2 L/min) to achieve a BIS value of 40-55, and a remi-
or re-operation occurs in 1-4% of patients,4-7 and severe 
cough may cause such bleeding.4,7 In addition to surgeon-re-
lated factors, anesthetic factors may also assist in prevention 
of post-thyroidectomy bleeding. A smooth extubation with-
out significant coughing or retching to avoid raised venous 
or arterial pressures are important considerations in mini-
mizing the risks of postoperative hemorrhage.7 During 
awakening from endotracheal anesthesia, the trachea may 
be stimulated by endotracheal tubes, by noxious effects of 
the anesthetic gas itself, or by uncleared secretions.3 The 
presence of an endotracheal tube during emergence from 
general anesthesia is often associated with severe cough.3,8 
Therefore, prevention of cough during emergence from gen-
eral anesthesia with the presence of a tracheal tube may be 
important in patients undergoing certain operations.
Intravenous opioids delivered at the end of surgery can 
facilitate smooth emergence by reducing coughing9,10 and 
attenuate deleterious hemodynamic changes.11 Specifically, 
administration of remifentanil via a target-controlled infu-
sion (TCI) makes it possible to reach a defined target con-
centration without concern that remifentanil levels will 
rapidly change or increase beyond the intended range.12 
Several previous studies, differing in type of surgery, com-
bined anesthetics, and patient sex, have demonstrated re-
ductions of airway reflexes during emergence with the use 
of remifentanil TCI;13,14 however, the recommended effec-
tive effect-site con centrations (effective Ce) of remifent-
anil for 50% of patients (EC50) reported in these studies 
range from 1.46 ng/mL to 2.35 ng/mL.13,14 
Numerous animal and human studies suggest that sex 
may affect opioid analgesia: that is, males require higher 
doses of opioids to achieve similar levels of analgesia as fe-
males.15-17 This sex difference is known to occur mainly 
with mu- and kappa-receptor agonists. Sex differences in 
appropriate opioid dose may affect not only the analgesic 
system but also act on other inherent properties of the en-
dogenous opioid receptor system, such as respiratory func-
tion.18 Mu- and kappa-opioid receptors in the brainstem 
contribute to regulation of the cough reflex.19 If there is the 
significant sex difference in remifentanil concentration for 
airway suppression during anesthetic emergence, a dose 
regimen suitable for one sex could be excessive for the oth-
er, and such information would be clinically important not 
only in respect of analgesic effect but also in preventing 
complications.
Accordingly, we hypothesized that men may require high-
er concentrations of remifentanil for cough suppression dur-
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ng/mL. Similarly, if the patient coughed at any time before, 
during, or after extubation, the pre-determined concentration 
was increased by 0.4 ng/mL. The upper concentration was 
limited to 3.0 ng/mL due to concerns for patient safety after 
extubation.8,14 The stopping rule, which required at least six 
pairs of failure/success, necessitated the recruitment of more 
than 20 patients.22 This up-and-down method was conducted 
independently for each sex. 
The MAP and HR were recorded at the following time 
points: T1, before induction of anesthesia (baseline); T2, 
end of surgery; T3, before extubation; T4, just after extuba-
tion; T5, 5 min after extubation; T6, 10 min after extuba-
tion; T7, before transfer out from the postanesthetic care 
unit. If MAP <60 mm Hg or HR <50 beats per min (beats/
min), we injected ephedrine 4 mg I.V. or atropine 0.5 mg 
I.V. immediately. In addition, respiratory rate (RR) was re-
corded at the T4-7 points. The time to eye opening (sevoflu-
rane off to eye opening) and time to extubation (sevoflurane 
off to extubation) were also recorded. Bradypnea, which was 
defined as a RR <8 breaths per min (bpm), and SpO2 below 
95% despite oxygen supplementation were monitored during 
the entire emergence period.
Patient data are presented as mean±standard deviation, or 
median and range, or numbers of patients. According to 
previous studies in which the EC50 was estimated by the 
Dixon’s method,13 the stopping rule required at least six 
pairs of failure/success. The EC50 of remifentanil was de-
fined as the mean value of the independent crossover pairs 
for each sex, and we compared the mean EC50s using a t-
test. To specify the precision of the target concentration, the 
isotonic regression method was also used for estimating 
EC50 and EC95 along with a confidence interval (CI).23 
From an observed response rate, which represents the ratio 
of the number of successful patients to the number of sub-
jects at each concentration level, an adjusted response prob-
ability was calculated by pooled adjacent-violators algo-
rithm (PAVA) in order to adhere to the assumption in dose-
response determinations that drug effect increases with 
increased dosage. The CI was estimated by a boot strapping 
approach.22,24 If the value of EC50 did not overlap at the lev-
el of 83% CI, the null hypothesis of equal concentration 
could be rejected as a type I error of 0.05.25 Other normally 
distributed variables were analyzed using t-tests. Chi-
square tests were used for intergroup comparisons of ordi-
nal variables. Statistical analyses were performed using 
SAS (version 9.2, SAS Inc., Cary, NC, USA), and all p-val-
ues less than 0.05 were considered significant.
fentanil Ce of 2-5 ng/mL was used to maintain patients’ 
mean arterial pressure (MAP) and heart rate (HR) within 
20% of baseline values. Mechanical ventilation was main-
tained with a tidal volume of 8 mL/kg, and ventilator fre-
quency was adjusted to maintain EtCO2 at 35-40 mm Hg. 
Nasopharyngeal temperature was maintained at 36-37°C.
Three anesthetists carried out this study. The first con-
ducted anesthetic induction, maintenance, and control of 
remifentanil concentration during the emergence period. 
The second, who did not know the remifentanil concentra-
tion during emergence, led anesthetic emergence and extu-
bation. The third anesthetist recorded all variables of inter-
est to this study, including cough grading and was blinded 
to the Ce of remifentanil. Ten min before the end of sur-
gery, sevoflurane was adjusted to an approximate BIS level 
of 60, and the remifentanil Ce was titrated to a pre-deter-
mined concentration (the initial Ce of remifentanil being 2 
ng/mL). This pre-determined Ce was maintained for at least 
15 min throughout emergence. When the operation was 
completed, 30 mg of ketorolac I.V. and 4 mg of ondanse-
tron I.V. were given, and 0.004 mg/kg of glycopyrrolate I.V. 
and 0.02 mg/kg of neostigmine I.V. were given to reverse 
neuromuscular block. Simultaneously, sevoflurane was dis-
continued, and fresh gas flow was increased to 10 L/min. 
Mechanical ventilation was converted to manual ventilation 
3 min after sevoflurane discontinuation, and EtCO2 was 
maintained at 45-55 mm Hg. During this phase, the patients 
were not disturbed, except for a verbal request to open their 
eyes. When the patients opened their eyes, deep breathing 
was encouraged. The tracheal tube was pulled when spon-
taneous respiration with an adequate tidal volume was con-
firmed. Immediately after extubation, remifentanil infusion 
was stopped, and oxygen was supplemented via a facemask 
for at least 10 min. 
Emergence cough was defined as the cough occurring 
from the time sevoflurane was turned off to 5 min after extu-
bation. The level of cough was assessed and recorded by the 
following cough grading system: Grade 0, no cough; Grade 
1, single cough with mild severity; Grade 2, cough persis-
tence less than 5 s with moderate severity; or Grade 3, se-
vere, persistent cough for more than 5 s. For estimation of the 
effective remifentanil Ce, the up-and-down sequential alloca-
tion design was used21 (i.e., the predetermined Ce of remifen-
tanil was determined according to the cough response of the 
previous patient). If the patient did not cough throughout the 
peri-extubation period, the pre-determined concentration of 
remifentanil for the subsequent patient was decreased by 0.4 
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during emergence based on Dixon’s method was signifi-
cantly less in females (1.23±0.21 ng/mL) than in males 
(2.43±0.21 ng/mL) (p<0.001). The use of isotonic regression 
estimator, with CIs derived by a bootstrapping approach, re-
vealed that the EC50 of remifentanil was significantly lower 
in females than in males [1.30 ng/mL (83% CI, 1.20-1.47 ng/
mL) vs. 2.57 ng/mL (83% CI, 2.45-2.70 ng/mL)]. Similarly, 
the EC95 was significantly lower in females than in males 
[1.86 ng/mL (95% CI, 1.56-1.96 ng/mL) vs. 2.96 ng/mL 
(95% CI, 2.77-2.98 ng/mL)] (Table 2). PAVA response rates 
of both sexes are presented in Fig. 2.
RR was 6.2, 9.1, 11.2, and 13.8 bpm at the T4-7 points, 
respectively, and RR at T5 and T6 points was significantly 
faster in females, though there was no difference of RR pat-
tern between sexes over time (p-value=0.28) (Fig. 3). In fe-
males, bradypnea, defined as a RR <8 bpm, was observed 
just after extubation (T4 point) in two of seven patients 
with a Ce of 1.6 ng/mL. In males, bradypnea was observed 
in two of 10 patients with a Ce of 2.4 ng/mL, in one of nine 
RESULTS
 
Twenty-three female patients and 30 male patients were en-
rolled in the study. Among the enrolled patients, three fe-
male patients were excluded due to surgical factors (nerve 
injury and delayed skin suture) and an incorrect pre-deter-
mined concentration of remifentanil. Five male patients 
were excluded due to surgical factors (converted from sim-
ple thyroidectomy to modified radical neck dissection) and 
delayed emergence. The patients’ characteristics are pre-
sented in Table 1. Age was comparable between the fe-
males and males; however, due to sex differences, patients’ 
height, weight, body surface area, and body mass index 
were significantly lower in females. Also, the number of 
patients for each cough grade was comparable between the 
females and males.
The up-and-down results in consecutive patients are shown 
in Fig. 1. The EC50 of remifentanil needed to prevent cough 
Table 1. Patient Characteristics
Male group (n=25) Female group (n=20) p value
Age 38.36±4.40   37.25±6.81 0.533
Height 173.20±4.22* 161.12±5.61 <0.001
Weight     75.62±11.46*   56.30±5.84 <0.001
BMI   25.22±3.80*   21.76±2.70 0.001
BSA       1.90±0.148*     1.59±0.09 <0.001
ASA physical status classification (%) 0.622
    1 22 (88) 18 (95)
    2   3 (12) 1 (5)
Sevoflurane vol% at BIS60   1.08±0.21     1.06±0.16 0.764
BMI, body mass index; BSA, body surface area.
Values are presented as median±SD or number (percentage).  
*p<0.05 between groups.
Fig. 1. Assessment of success or failure of smooth emergence over the predetermined concentration of remifentanil based on consecutive patients by 
Dixon’s up-and-down method. Mean EC50 for smooth emergence was calculated from cross-over pairs from failure (open circle) to success (closed circle) 
in 25 male patients (A) and 20 female patients (B). EC50, effective effect-site concentration (Ce) of remifentanil for suppression of emergence cough in 50% of 
patients.
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propofol anesthesia for nasal surgery. The most notable dif-
ference between the two studies was the type of surgery; in 
addition, the proportion of male patients in the former study 
was 14%, whereas it was 62% in the latter. It is not surprising 
that the opioid requirements differed by sex, but other con-
founding factors should be excluded. Therefore, we conduct-
ed the present study for sex comparison only. Based on our 
results, the concentrations required for cough suppression 
during anesthetic emergence under the same clinical condi-
tions were significantly different between sexes. One inter-
esting point is that the cough sensitivity of females was lower 
than that of males. Dicpinigaitis and Rauf27 reported that 
healthy women have a more sensitive cough reflex than 
healthy men. Nevertheless, the antitussive effect was 
patients with a Ce of 2.8 ng/mL, and in one of two patients 
with a Ce of 3.0 ng/mL. One male patient with a Ce of 2.8 
ng/mL developed upper airway obstruction and experi-
enced a brief desaturation episode. All of these patients 
who had adverse respiratory events returned to a normal re-
spiratory pattern within 5 min by encouragement of deep 
breathing via facial mask without ventilatory support. 
The time to eye opening was significantly shorter in fe-
males (6.50±1.64 min) than in males (10.01±4.43 min) (p< 
0.001). The time to extubation was also significantly shorter 
in females (7.66±1.91 min) than in males (11.27±4.95 min) 
(p<0.001) (Table 3). 
MAP and HR over time did not differ significantly be-
tween the sexes [p-value=0.35 (MAP) and 0.082 (HR)] 
(Fig. 3). The MAP of females was significantly lower than 
that of males at the T2, T6 and T7 points. HR did not differ 
between sexes at any time point.
DISCUSSION
In the present study, we found that the remifentanil require-
ment for cough suppression during anesthetic emergence in 
50% patients was 1.30 ng/mL in females, which was about 
half of the concentration in males (2.57 ng/mL).
Several studies have investigated the effective Ce of remi-
fentanil for preventing airway reflexes during anesthetic 
emergence. Jun, et al.26 demonstrated that 1.5 ng/mL of remi-
fentanil effectively suppressed cough during emergence from 
sevoflurane-remifentanil anesthesia for thyroid surgery. 
However, Chen, et al.8 reported that 2-2.5 ng/mL was needed 
to achieve the antitussive effect of remifentanil, following 
Table 2. EC50 and EC95 of Remifentanil for Emergence without Cough
M F
Isotonic regression (EC50, 83% CI)* 2.57 (2.45-2.70) 1.30 (1.20-1.47)
Isotonic regression (EC95, 95% CI)
† 2.96 (2.77-2.98) 1.86 (1.56-1.96)
PAVA, pooled-adjacent-violators algorithm; CI, confidence interval; EC50, effective Ce of remifentanil for suppression of emergence cough in 50% of pa-
tients; EC95, effective Ce of remifentanil for suppression of emergence cough in 95% of patients. 
Values are presented as the mean (83%* or 95%† CI). EC50 and EC95 were calculated by isotonic regression method using the PAVA, and CIs were calcu-
lated using a bootstrapping approach. 
Fig. 2. Pooled-adjacent-violators algorithm response rate in female (▲) and 
male (●) groups. EC50 of remifentanil in females was 1.30 ng/mL (83% CI, 
1.20-1.47 ng/mL) and 2.57 ng/mL (83% CI, 2.45-2.70 ng/mL) in males. EC95 in fe-
males was 1.86 ng/mL (95% CI, 1.56-1.96 ng/mL) and 2.96 ng/mL (95% CI, 
2.77-2.98 ng/mL) in males. Both EC50 and EC95 were significantly lower in the 
female group than in the male group. EC50, effective Ce of remifentanil for 
suppression of emergence cough in 50% of patients; EC95, effective Ce of 
remifentanil for suppression of emergence cough in 95% of patients; CI, 
confidence interval.
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Table 3. The Time to Eye Opening and the Time to Extubation in Males and Females
Male group (n=25) Female group (n=20) p value
Time to eye opening (min) 10.01±4.43 6.50±1.64 <0.001
Time to extubation (min) 11.27±4.95 7.66±1.91   0.002
SD, standard deviation.
Values are presented as mean±SD. The time to eye opening was defined as the time from sevoflurane discontinuation to eye opening. The time to extuba-
tion was defined as the time from sevoflurane discontinuation to extubation. 
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cortical and sub-cortical areas.37 Similarly, Zubieta, et al.38 
found that tonic experimental pain produced a greater de-
crease in mu-opioid receptor availability in several brain re-
gions among men compared to women, apparently due to in-
creased pain-induced binding of endogenous ligand to the 
receptor. Therefore, the authors suggested that the higher mu-
opioid receptor availability among females might explain 
their increased analgesic responses to exogenous opioids. This 
pharmacodynamic difference can be expected in remifentanil 
also, and our results did demonstrate a sex difference for 
cough suppression. 
Several clinical studies have reported respiratory compli-
cations at concentrations over 2.5 ng/mL (Ce of remifent-
anil),8,14 and our research did as well. Though the respirato-
ry complications were not severe and resolved spontaneously 
or with minimal treatment, further studies regarding the 
safety of the suggested EC95 are necessary for generalized 
application of high concentrations of remifentanil. 
There are some limitations to the present study. First, we 
did not measure plasma concentrations of remifentanil. Rath-
er, we calculated the predicted value using Minto’s pharma-
cokinetic model, which is widely used in clinical settings 
with acceptable levels of bias and inaccuracy.39 Second, the 
types of surgery included were limited. Thyroid surgery may 
involve more tracheal irritation than other surgeries, and 
therefore, caution is needed in extrapolating the findings of 
this study to other types of surgery.
In conclusion, when remifentanil TCI is used for cough 
prevention during anesthetic emergence, patient sex may be 
an important factor for the determination of optimal remi-
fentanil concentrations. Overall, females require lower con-
centrations of remifentanil for this purpose than do males.
achieved at a lower concentration of remifentanil in females 
than in males. Male patients with a Ce of 2.0 ng/mL will def-
initely suffer from severe cough during emergence, while fe-
male patients with the same Ce will never cough.
In recent years, there has been growing interest in study-
ing sex differences in anesthetic pharmacology. Compared 
to males, females are less sensitive to the anesthetic effects 
of propofol28,29 and ropivacaine,30 but are more sensitive to 
vecuronium31,32 and rocuronium.33 Of the anesthetic drugs, 
morphine is the most commonly studied with regard to sex 
differences, and several studies have shown that females 
are more sensitive to the analgesic effects of morphine than 
are males.34,35 Sex differences related to opioids are not re-
stricted to analgesic properties, but are also present in other 
opioid-mediated responses, including the respiratory sys-
tem. For instance, morphine has a greater effect on decreas-
ing ventilatory response to carbon dioxide and hypoxic sen-
sitivity in females than in males.18 Most of these studies did 
not measure morphine or morphine glucuronide concentra-
tion and pharmokinetic differences could not be excluded; 
nevertheless, the major difference is thought to be pharma-
codynamic.17 
Remifentanil TCI was derived from the results of pharma-
cokinetic and pharmacodynamic studies, which demonstrated 
that there are no sex differences related to pharmacokinetic or 
electroencephalogram (EEG) variables.20 However, there is a 
lack of studies about the differential effect of remifentanil 
based on sex,36 and the clinical effects of opioids may differ 
from EEG variables. Experimental studies for mu-opioid re-
ceptor binding, measured by positron emission tomography 
(PET), illustrated that premenopausal females have signifi-
cantly higher mu-receptor binding potential than males in the 
Fig. 3. MAP, HR, and RR were not significantly different in females (▲) and males (●) over time (p-values for MAP, HR, and RR=0.351, 0.082 and 0.277, respec-
tively). The female MAP was significantly higher than that of males at the end of the surgery, 10 min after extubation, and before transfer out from the post-
anesthetic care unit (p=0.012, p<0.001, and p<0.001, respectively). With regard to HR, there was no significant difference at any time point. RR increased con-
tinuously from each prior time point in both males and females: just after extubation to 5 min after extubation (p<0.001), 5 min after extubation to10 min after 
extubation (p<0.001), and 10 min after extubation to before transfer out from the post-anesthetic care unit (p<0.001). MAP, mean arterial pressure; HR, heart 
rate; RR, respiratory rate; bpm, breaths per min.
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